Association Between COVID-19 and Mortality in Hip Fracture Surgery in the National COVID Cohort Collaborative (N3C):

Eli B Levitt1, David A Patch, Scott Mabry

  • 1From the Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, AL (Mr. Levitt, Dr. Patch, Dr. Mabry, Dr. Quade, Dr. Theiss, Dr. Spitler, and Dr. Johnson); the Department of Translational Medicine, Florida International University Herbert Wertheim College of Medicine, Miami, FL (Mr. Levitt and Dr. Terrero); the Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL (Dr. Jaeger); the Center for Health AI, University of Colorado Anschutz Medical Campus, Aurora, CO (Dr. Haendel); the Schools of Medicine, Public Health, and Nursing, Johns Hopkins University, Baltimore, MD (Dr. Chute); and the Department of Orthopaedics, Hughston Clinic, Columbus, GA (Dr. Ponce).

Insights

Hip fracture surgery patients with coronavirus disease (COVID-19) had higher mortality. This national study found 30-day mortality was 14.6% for COVID-19 positive versus 3.8% for negative patients.

Area of Science:

  • Geriatric Surgery
  • Infectious Diseases
  • Orthopedic Surgery

Background:

  • Investigated outcomes of hip fracture surgery in patients with coronavirus disease (COVID-19).
  • Utilized a national database for comprehensive data analysis.

Purpose of the Study:

  • To compare hip fracture surgery outcomes between COVID-19 positive and negative patient cohorts.
  • To assess the impact of COVID-19 on mortality following hip fracture surgery.

Main Methods:

  • Retrospective cohort study design.
  • Inclusion of patients aged 65 and older undergoing hip fracture surgery between March 15 and December 31, 2020.
  • Matched cohorts from 46 US sites, comparing COVID-19 positive and negative groups.

Main Results:

  • 30-day all-cause mortality was significantly higher in COVID-19 positive patients (14.6%) compared to COVID-19 negative patients (3.8%).
  • All-cause mortality for hip fracture surgery in the COVID-19 positive group was 27.0% during the study period.
  • A notable difference in mortality was observed between the two groups.

Conclusions:

  • Patients with COVID-19 undergoing hip fracture surgery experience a higher incidence of all-cause mortality.
  • Mortality rates in this national analysis were lower than some reported local and regional studies.
  • Findings can inform clinical management strategies for hip fracture patients diagnosed with COVID-19.
Abstract